EarningsQ4 2023 Earnings Report

Lakefront Biotherapeutics NV (GLPGN) Q4 2023 Earnings Report

― Followers

MX:GLPGN Q4 2023 EPS Results

Actual EPS$48.35

Consensus EPS-$39.96

Beat/MissBeat by +$88.31

One Year Ago EPS-$63.73

Actual Revenue―

Expected Revenue$1.48B

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2023

Date02/22/2024

TimeAfter Close

Conference CallThursday, February 22, 2024

MX:GLPGN Upcoming Earnings

Lakefront Biotherapeutics NV's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 12, 2026	2026 (Q3)	-14.53 / -	-62.109	―
Aug 10, 2026	2026 (Q2)	-14.16 / 0.61	-31.965	101.90% (+32.57)
May 06, 2026	2026 (Q1)	-16.49 / 4.25	-47.543	108.94% (+51.79)
Feb 23, 2026	2025 (Q4)	-2.23 / 240.14	5.847	4007.27% (+234.30)
Nov 05, 2025	2025 (Q3)	-8.29 / -62.11	-14.971	-314.86% (-47.14)
Jul 23, 2025	2025 (Q2)	-4.03 / -31.97	1.416	-2357.14% (-33.38)
Apr 23, 2025	2025 (Q1)	-2.75 / -47.54	7.283	-752.78% (-54.83)
Feb 12, 2025	2024 (Q4)	-10.34 / 5.85	48.352	-87.91% (-42.51)
Oct 30, 2024	2024 (Q3)	-3.14 / -14.97	7.89	-289.74% (-22.86)
Aug 01, 2024	2024 (Q2)	-1.38 / 1.42	1.618	-12.50% (-0.20)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed